Showing 9 posts of 9 posts found.

doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

NHS image

PPRS deal ‘dreadful’, says EMIG

November 26, 2013
Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

NICE image

NICE to assess drug value

March 22, 2013
Sales and Marketing EMIG, NHS, NICE, VBP

NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011
Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …

Generic substitution will not deliver significant NHS savings, says EMIG

March 31, 2010
Sales and Marketing EMIG, NHS, generics

The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …

Latest content